Clinical Trial Update: NexGen EBA Radiologic and Immunologic Biomarkers of Sterilizing Drug Activity in Tuberculosis [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating radiologic and immunologic biomarkers of sterilizing drug activity in pulmonary tuberculosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Tuberculosis

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Pulmonary Tuberculosis | Phase 2 | Status: COMPLETED